| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 18 | 2013 | 475 | 1.320 |
Why?
|
| Receptors, Estrogen | 19 | 2010 | 830 | 1.200 |
Why?
|
| Selective Estrogen Receptor Modulators | 6 | 2014 | 63 | 0.780 |
Why?
|
| Tamoxifen | 9 | 2012 | 377 | 0.760 |
Why?
|
| Transcortin | 16 | 1994 | 19 | 0.740 |
Why?
|
| Estrogen Receptor beta | 5 | 2012 | 87 | 0.730 |
Why?
|
| Estradiol | 15 | 2012 | 559 | 0.610 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2012 | 186 | 0.590 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2014 | 558 | 0.580 |
Why?
|
| Transcription Factors | 13 | 2009 | 2728 | 0.540 |
Why?
|
| Estrogen Antagonists | 6 | 2012 | 107 | 0.540 |
Why?
|
| Raloxifene Hydrochloride | 2 | 2012 | 18 | 0.460 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2014 | 17 | 0.450 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2014 | 51 | 0.440 |
Why?
|
| Trans-Activators | 8 | 2005 | 838 | 0.440 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 2 | 2012 | 38 | 0.430 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 2127 | 0.420 |
Why?
|
| Estrogens | 6 | 2009 | 525 | 0.410 |
Why?
|
| Indoles | 1 | 2014 | 203 | 0.410 |
Why?
|
| Breast | 1 | 2014 | 218 | 0.400 |
Why?
|
| Breast Neoplasms | 5 | 2013 | 2771 | 0.330 |
Why?
|
| HeLa Cells | 14 | 2009 | 837 | 0.310 |
Why?
|
| Transcription, Genetic | 9 | 2013 | 1761 | 0.310 |
Why?
|
| RNA, Messenger | 13 | 2014 | 2910 | 0.290 |
Why?
|
| Urogenital Neoplasms | 1 | 2007 | 16 | 0.270 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 52 | 0.250 |
Why?
|
| Ligands | 12 | 2010 | 572 | 0.250 |
Why?
|
| Apoptosis | 1 | 2012 | 1940 | 0.240 |
Why?
|
| Histone Acetyltransferases | 10 | 2006 | 318 | 0.240 |
Why?
|
| Cell Proliferation | 1 | 2012 | 2557 | 0.230 |
Why?
|
| Transcriptional Activation | 6 | 2009 | 501 | 0.230 |
Why?
|
| Cell Line, Tumor | 7 | 2012 | 3781 | 0.220 |
Why?
|
| Receptors, Steroid | 6 | 2006 | 276 | 0.220 |
Why?
|
| Hydrocortisone | 5 | 1994 | 246 | 0.210 |
Why?
|
| Benzazepines | 1 | 2001 | 61 | 0.180 |
Why?
|
| Down-Regulation | 3 | 2014 | 718 | 0.180 |
Why?
|
| Transcription Factor AP-1 | 1 | 2001 | 112 | 0.180 |
Why?
|
| Signal Transduction | 7 | 2014 | 4927 | 0.180 |
Why?
|
| Tumor Cells, Cultured | 7 | 2006 | 1106 | 0.170 |
Why?
|
| Growth Substances | 2 | 1998 | 114 | 0.170 |
Why?
|
| Nuclear Receptor Coactivator 1 | 8 | 2006 | 244 | 0.170 |
Why?
|
| Base Sequence | 15 | 2001 | 3177 | 0.160 |
Why?
|
| DNA | 11 | 2005 | 1680 | 0.160 |
Why?
|
| Phosphorylation | 7 | 2009 | 1711 | 0.150 |
Why?
|
| Nuclear Proteins | 4 | 2005 | 1343 | 0.150 |
Why?
|
| CREB-Binding Protein | 3 | 2006 | 66 | 0.150 |
Why?
|
| Anti-Allergic Agents | 1 | 1998 | 27 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 5 | 2009 | 787 | 0.140 |
Why?
|
| Humans | 45 | 2014 | 134032 | 0.140 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1998 | 128 | 0.140 |
Why?
|
| Protein Binding | 6 | 2006 | 1854 | 0.140 |
Why?
|
| Anti-Asthmatic Agents | 1 | 1998 | 124 | 0.130 |
Why?
|
| Dopamine | 3 | 1996 | 286 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 3 | 4 | 2009 | 351 | 0.120 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 1994 | 49 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 1998 | 402 | 0.120 |
Why?
|
| Steroids | 1 | 1996 | 213 | 0.120 |
Why?
|
| Molecular Sequence Data | 13 | 2000 | 3979 | 0.120 |
Why?
|
| Acetyltransferases | 2 | 2005 | 92 | 0.120 |
Why?
|
| Liver | 8 | 1993 | 1880 | 0.110 |
Why?
|
| Oncogene Proteins | 2 | 2005 | 156 | 0.110 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2014 | 31 | 0.110 |
Why?
|
| Virus Integration | 1 | 2014 | 40 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2006 | 2174 | 0.110 |
Why?
|
| Animals | 27 | 2009 | 36524 | 0.100 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2013 | 39 | 0.100 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2012 | 21 | 0.100 |
Why?
|
| Cell Nucleolus | 1 | 2012 | 51 | 0.100 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 143 | 0.100 |
Why?
|
| Histidine | 1 | 1992 | 75 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2012 | 141 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 65 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 60 | 0.100 |
Why?
|
| Cyclin D1 | 1 | 2012 | 123 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 1997 | 871 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2014 | 345 | 0.090 |
Why?
|
| MCF-7 Cells | 1 | 2012 | 233 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 352 | 0.090 |
Why?
|
| Thyroxine | 1 | 1992 | 76 | 0.090 |
Why?
|
| Bone Density | 1 | 2014 | 375 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2014 | 627 | 0.090 |
Why?
|
| Hormones | 1 | 1992 | 197 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 455 | 0.090 |
Why?
|
| Leucine | 1 | 1992 | 312 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 407 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 509 | 0.090 |
Why?
|
| Receptors, Progesterone | 7 | 2006 | 898 | 0.090 |
Why?
|
| Gene Expression Regulation | 5 | 2009 | 2664 | 0.090 |
Why?
|
| Rats | 9 | 2004 | 3890 | 0.080 |
Why?
|
| Genes | 3 | 1991 | 450 | 0.080 |
Why?
|
| Dexamethasone | 1 | 1992 | 281 | 0.080 |
Why?
|
| Chromatin | 1 | 2014 | 615 | 0.080 |
Why?
|
| Binding Sites | 7 | 2010 | 1382 | 0.080 |
Why?
|
| Casein Kinase II | 1 | 2009 | 15 | 0.080 |
Why?
|
| Genes, Overlapping | 1 | 1989 | 7 | 0.080 |
Why?
|
| Androgen-Binding Protein | 1 | 1989 | 26 | 0.080 |
Why?
|
| Female | 18 | 2014 | 71818 | 0.080 |
Why?
|
| Multienzyme Complexes | 2 | 2001 | 89 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 2 | 2001 | 119 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 510 | 0.080 |
Why?
|
| Casein Kinase Idelta | 1 | 2009 | 5 | 0.080 |
Why?
|
| Amino Acid Sequence | 11 | 2000 | 2793 | 0.080 |
Why?
|
| Cell Nucleus | 3 | 2005 | 689 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 1331 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1597 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2014 | 876 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 1388 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2010 | 329 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 1737 | 0.070 |
Why?
|
| Testis | 1 | 1989 | 433 | 0.070 |
Why?
|
| Exons | 1 | 1989 | 835 | 0.070 |
Why?
|
| Activating Transcription Factors | 1 | 2006 | 4 | 0.070 |
Why?
|
| CHO Cells | 4 | 2001 | 167 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 275 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2014 | 952 | 0.060 |
Why?
|
| Nandrolone | 1 | 2006 | 6 | 0.060 |
Why?
|
| Nuclear Matrix | 3 | 2001 | 21 | 0.060 |
Why?
|
| Cricetinae | 4 | 2001 | 398 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 1083 | 0.060 |
Why?
|
| Progestins | 2 | 2006 | 53 | 0.060 |
Why?
|
| Cloning, Molecular | 5 | 1999 | 912 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1315 | 0.060 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 83 | 0.060 |
Why?
|
| Receptors, Dopamine | 2 | 1996 | 41 | 0.060 |
Why?
|
| DNA Primers | 3 | 2001 | 672 | 0.060 |
Why?
|
| Fetus | 4 | 1993 | 599 | 0.060 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2004 | 11 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2001 | 276 | 0.060 |
Why?
|
| Biological Transport | 3 | 2001 | 371 | 0.060 |
Why?
|
| Transfection | 6 | 2006 | 1096 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2005 | 303 | 0.060 |
Why?
|
| Middle Aged | 3 | 2014 | 29393 | 0.060 |
Why?
|
| Protein Kinase C | 2 | 2001 | 151 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 69 | 0.050 |
Why?
|
| Myelin P0 Protein | 1 | 2004 | 29 | 0.050 |
Why?
|
| Mutation | 6 | 2010 | 6304 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2005 | 320 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 161 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2006 | 1430 | 0.050 |
Why?
|
| Aging | 1 | 1991 | 1305 | 0.050 |
Why?
|
| Gravitation | 1 | 2002 | 13 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 719 | 0.050 |
Why?
|
| Ligases | 2 | 2000 | 48 | 0.050 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2004 | 211 | 0.050 |
Why?
|
| Calcitriol | 1 | 2002 | 81 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 1440 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2002 | 74 | 0.050 |
Why?
|
| Inositol Phosphates | 1 | 2001 | 13 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2001 | 649 | 0.050 |
Why?
|
| Cell Line | 3 | 2009 | 2858 | 0.050 |
Why?
|
| Lac Operon | 1 | 2001 | 96 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2001 | 397 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2001 | 806 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 172 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 212 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 717 | 0.040 |
Why?
|
| Norpregnenes | 2 | 2001 | 3 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2004 | 922 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2000 | 149 | 0.040 |
Why?
|
| Sexual Behavior, Animal | 2 | 1996 | 88 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1999 | 46 | 0.040 |
Why?
|
| Posture | 2 | 1996 | 157 | 0.040 |
Why?
|
| Drug Design | 1 | 1999 | 168 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1999 | 73 | 0.040 |
Why?
|
| Response Elements | 1 | 1998 | 107 | 0.040 |
Why?
|
| Antibodies, Phospho-Specific | 2 | 2009 | 3 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 1992 | 1044 | 0.040 |
Why?
|
| Neutrophils | 2 | 1990 | 401 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 117 | 0.030 |
Why?
|
| Plasmids | 1 | 1998 | 529 | 0.030 |
Why?
|
| Kinetics | 5 | 2000 | 1356 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2010 | 873 | 0.030 |
Why?
|
| Leupeptins | 3 | 2001 | 26 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2001 | 41 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 2 | 1993 | 136 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1996 | 88 | 0.030 |
Why?
|
| Glycosylation | 2 | 1992 | 128 | 0.030 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1994 | 15 | 0.030 |
Why?
|
| Desogestrel | 1 | 1994 | 7 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1994 | 1627 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1998 | 970 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1991 | 311 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 236 | 0.030 |
Why?
|
| Half-Life | 2 | 1991 | 161 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1993 | 80 | 0.030 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1993 | 29 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 328 | 0.030 |
Why?
|
| Mice | 3 | 2007 | 19030 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2005 | 211 | 0.030 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 1992 | 17 | 0.030 |
Why?
|
| Fetal Blood | 2 | 1991 | 178 | 0.030 |
Why?
|
| Catalysis | 1 | 2013 | 138 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 295 | 0.020 |
Why?
|
| Rats, Inbred BB | 1 | 1991 | 5 | 0.020 |
Why?
|
| Deoxyribonucleotides | 1 | 1991 | 10 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 307 | 0.020 |
Why?
|
| Corticosterone | 1 | 1991 | 63 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 371 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2007 | 13050 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1993 | 466 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 64 | 0.020 |
Why?
|
| Models, Biological | 1 | 1995 | 1535 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 1990 | 75 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2001 | 166 | 0.020 |
Why?
|
| Pregnancy | 6 | 1993 | 7568 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 336 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 284 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1146 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 840 | 0.020 |
Why?
|
| Leukocytes | 1 | 1990 | 223 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1989 | 85 | 0.020 |
Why?
|
| Gene Library | 1 | 1989 | 225 | 0.020 |
Why?
|
| Progesterone | 2 | 2006 | 635 | 0.020 |
Why?
|
| Amino Acids | 1 | 1991 | 687 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 413 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 1989 | 154 | 0.020 |
Why?
|
| Serine | 1 | 2009 | 185 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2004 | 3181 | 0.020 |
Why?
|
| In Vitro Techniques | 3 | 1999 | 993 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 546 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1987 | 100 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2000 | 391 | 0.020 |
Why?
|
| Trypsin | 1 | 2006 | 95 | 0.020 |
Why?
|
| Mifepristone | 1 | 2006 | 139 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2005 | 25 | 0.020 |
Why?
|
| Valine | 1 | 1985 | 116 | 0.010 |
Why?
|
| Jejunum | 1 | 1985 | 131 | 0.010 |
Why?
|
| Rabbits | 3 | 1991 | 729 | 0.010 |
Why?
|
| Lysine | 1 | 1985 | 207 | 0.010 |
Why?
|
| Molecular Weight | 3 | 1990 | 388 | 0.010 |
Why?
|
| Biglycan | 1 | 2004 | 7 | 0.010 |
Why?
|
| Sequence Alignment | 2 | 2000 | 633 | 0.010 |
Why?
|
| Collagen Type III | 1 | 2004 | 26 | 0.010 |
Why?
|
| Blotting, Western | 2 | 2001 | 1140 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2004 | 94 | 0.010 |
Why?
|
| 20-alpha-Dihydroprogesterone | 1 | 2004 | 1 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 3228 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2004 | 130 | 0.010 |
Why?
|
| In Situ Hybridization | 2 | 1996 | 485 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 177 | 0.010 |
Why?
|
| Lung | 2 | 1992 | 1580 | 0.010 |
Why?
|
| Schwann Cells | 1 | 2004 | 68 | 0.010 |
Why?
|
| Male | 6 | 2004 | 66022 | 0.010 |
Why?
|
| Norethindrone | 1 | 2001 | 8 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 2001 | 11 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 2001 | 20 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 294 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2001 | 66 | 0.010 |
Why?
|
| Tissue Distribution | 2 | 1992 | 402 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 231 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 171 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 1218 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2001 | 320 | 0.010 |
Why?
|
| Granulocytes | 2 | 1990 | 71 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2001 | 469 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6604 | 0.010 |
Why?
|
| DNA Replication | 1 | 2001 | 364 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1999 | 87 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 357 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 402 | 0.010 |
Why?
|
| Gene Expression | 2 | 1994 | 1621 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1999 | 313 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 609 | 0.010 |
Why?
|
| Placenta | 2 | 1993 | 536 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1999 | 87 | 0.010 |
Why?
|
| Arabidopsis | 1 | 1999 | 94 | 0.010 |
Why?
|
| Mammals | 1 | 1999 | 280 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 810 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1996 | 31 | 0.010 |
Why?
|
| Aged | 2 | 1992 | 21750 | 0.010 |
Why?
|
| Dopamine Antagonists | 1 | 1996 | 50 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1996 | 89 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2001 | 934 | 0.010 |
Why?
|
| Ethinyl Estradiol | 1 | 1994 | 11 | 0.010 |
Why?
|
| Biological Availability | 1 | 1994 | 153 | 0.010 |
Why?
|
| Saimiri | 1 | 1994 | 11 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 169 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 186 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 1070 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1994 | 330 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1999 | 1027 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 472 | 0.010 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 1992 | 4 | 0.010 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1992 | 21 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 139 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 673 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1992 | 54 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 272 | 0.010 |
Why?
|
| Sheep | 1 | 1992 | 237 | 0.010 |
Why?
|
| Serpins | 1 | 1991 | 34 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1992 | 223 | 0.010 |
Why?
|
| Pancreatic Elastase | 1 | 1990 | 14 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1990 | 58 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1990 | 85 | 0.010 |
Why?
|
| Autoradiography | 1 | 1989 | 73 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1989 | 79 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1993 | 1764 | 0.000 |
Why?
|
| Phenotype | 1 | 1999 | 4554 | 0.000 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1990 | 358 | 0.000 |
Why?
|
| Monocytes | 1 | 1990 | 360 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 106 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1987 | 119 | 0.000 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1987 | 103 | 0.000 |
Why?
|
| Serine Endopeptidases | 1 | 1987 | 204 | 0.000 |
Why?
|
| Gestational Age | 1 | 1990 | 1227 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1990 | 834 | 0.000 |
Why?
|
| Animals, Suckling | 1 | 1985 | 51 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1985 | 89 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1985 | 193 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 13181 | 0.000 |
Why?
|
| Inflammation | 1 | 1990 | 1595 | 0.000 |
Why?
|
| Adult | 2 | 1994 | 31958 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1985 | 815 | 0.000 |
Why?
|
| Age Factors | 1 | 1985 | 2994 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1990 | 7207 | 0.000 |
Why?
|